Chris has over 35 years of engineering experience, managing over $1 Billion in project value, construction management, commissioning and validation of technically complex projects within the pharmaceutical, biotechnology, semiconductor, specialty chemical, food, healthcare, and science and technology business sectors. He has completed projects successfully for a diverse portfolio of clients, across the country from Fortune 500 to venture capitalized start-up companies.

In addition to his design-build expertise, Chris has in-depth knowledge in assessing high-tech real estate assets for adaptive re-use to accommodate R&D, pilot, clinical and full scale manufacturing and packaging operations across multiple regulated market sectors for both owner operators, tenants, landlords and developers.

As President of leveraged Design/Build construction firm PROTECS, Chris leads his team in meeting client’s strategic objectives. As the patent holder of the “Method of Designing and Building to a Targeted Cost for High Tech Facilities”, his expertise is focusing the design effort to meet a “targeted cost” from the onset of the project regardless of size, complexity or market sector involved. By doing so, PROTECS assists clients to meet or exceed their performance, conformance, compliance, time-to-market, and capital budget goals.